Chinese Gene Firm Providing Worldwide COVID Tests Has Ties To The Chinese Military
FILE PHOTO: Technicians work at a genetic testing laboratory of BGI, formerly known as Beijing Genomics Institute, in Kunming, Yunnan province, China December 26, 2018. REUTERS/Stringer
SYDNEY (Reuters) - BGI Group, the world’s largest genomics company, has worked with China’s military on research that ranges from mass testing for respiratory pathogens to brain science, a Reuters review of research, patent filings and other documents has found.
The review, of more than 40 publicly available documents and research papers in Chinese and English, shows BGI’s links to the People’s Liberation Army (PLA) include research with China’s top military supercomputing experts.
The extent of those links has not previously been reported. BGI has sold millions of COVID-19 test kits outside China since the outbreak of the new coronavirus pandemic, including to Europe, Australia and the United States.
Shares of BGI Genomics Co, the company’s subsidiary listed on the Shenzhen stock exchange, have doubled in price over the past 12 months, giving it a market value of about $9 billion.
Read more ....
Previous Post: U.S. Intelligence Officials Are Saying The Chinese Government Is Collecting Americans' DNA (January 29, 2021).
WNU Editor: Rule of thumb when it comes to large Chinese companies. They must always comply to what the Chinese government tells them to do, and in this case it will not be a stretch to say that the Chinese government wants a data base of DNA from around the world.
More News On The Chinese Gene Firm Providing Worldwide COVID Tests Having Ties With The Chinese Military
Chinese biotech firm offered to build COVID labs in US, likely to try to collect Americans' DNA: report -- FOX News
China Genetics Firms Covertly 'Harvesting' Americans' DNA Via COVID Tests, Claims US Intelligence -- Sputnik
from War News Updates https://ift.tt/3oChDVL
Chinese Gene Firm Providing Worldwide COVID Tests Has Ties To The Chinese Military
Reviewed by crazy
on
7:38 AM
Rating:
No comments: